Heron Therapeutics (HRTX) Cash US GAAP (year values)

FY2021 FY2022 FY2023 FY2024 FY2025   LTM ? CAGR 5 years ?
Cash, bln rub 157.6 84.9 80.4 59.3 46.6   44.8  
Changes by years, y/y, % -24% -46% -5% -26% -21%     -25.9%

Heron Therapeutics. Cash, bln rub

Heron Therapeutics. Cash, changes, %

Heron Therapeutics (HRTX) Cash US GAAP (quarter values)

FY2025Q1 FY2025Q2 FY2025Q3 FY2025Q4 FY2026Q1   LTM ?
Cash, bln rub 50.7 40.6 55.5 46.6 44.8   44.8
Changes by years, y/y, % -29% -40% -22% -21% -12%    
Changes by quarters, q/q, % -15% -20% +37% -16% -4%    

Heron Therapeutics. Cash, bln rub

Heron Therapeutics. Cash, changes, y/y, %

Heron Therapeutics. Cash, changes, q/q, %